You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 9,676,870

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,676,870

Title:	Methods of treating atherosclerosis and aneurysm
Abstract:	The technology described herein is directed to methods of treating cardiovascular and metabolic disorders.
Inventor(s):	Shi; Guo-Ping (Newton, MA)
Assignee:	The Brigham and Women\'s Hospital, Inc. (Boston, MA)
Application Number:	14/236,544
Patent Claims:	1. A method comprising, administering a therapeutically effective amount of an IgE signaling inhibitor to a subject in need of a treatment for atherosclerosis, wherein the IgE inhibitor binds to IgE and inhibits the binding of IgE to a receptor molecule. 2. A method comprising, administering a therapeutically effective amount of an IgE signaling inhibitor to a subject in need of a treatment for abdominal aortic aneurysm, wherein the IgE inhibitor binds to IgE and inhibits the binding of IgE to a receptor molecule. 3. The method of claim 1, wherein the IgE inhibitor is selected from the group consisting of; an IgE monoclonal antibody; omalizumab; and talizumab. 4. The method of claim 2, wherein the IgE inhibitor is selected from the group consisting of; an anti-IgE monoclonal antibody; omalizumab; and talizumab.

Details for Patent 9,676,870

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	XOLAIR	omalizumab	For Injection	103976	06/20/2003	⤷ Try a Trial	2031-08-04
Genentech, Inc.	XOLAIR	omalizumab	Injection	103976	09/28/2018	⤷ Try a Trial	2031-08-04
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.